Strategic communications and investor engagement for life sciences companies at pivotal moments

Putnam Insights advises emerging life sciences companies on the communications, positioning, and stakeholder strategies that support fundraising, clinical development, commercialization, reputation, and long-term growth.

We work alongside founders and executive leadership teams to define the company story, sharpen how it is communicated, and make sure it holds up across the conversations that matter most, from investors and strategic partners to media and other industry stakeholders.

Our work spans enterprise positioning, investor communications and engagement, executive preparation, media strategy, thought leadership, and milestone communications. By bringing these efforts together, we help companies communicate with greater clarity, build credibility with the audiences that matter, and create stronger alignment between where the business is today and where it is going.

What We Advise On

Rare disease demands more—and so do we. With a global footprint of approved products and a broad pipeline of investigational medicines, we are advancing
therapies that expand what patients and families can expect—today and in the years ahead.

LIFE SCIENCES LIFECYCLE

Built for the inflection points.

Communications requirements change as a life sciences company grows. The story that works in formation or seed financing may not be enough for institutional investors, clinical stakeholders, strategic partners, or the market at large

As the company evolves, the conversation with investors continues.


Communications needs change as a life sciences company grows. Putnam Insights brings senior counsel to the moments when the narrative, audience, and stakes shift.

01
Company formation and corporate positioning
02
Seed, Series A, and growth financing
03
Preclinical and clinical development
04
Regulatory and scientific milestones
05
Strategic partnerships and transactions
06
Commercialization and market preparation
07
Corporate reputation and issues management

FEATURED ENGAGEMENT

Enterprise Narrative Sprint

One strategic foundation for every stakeholder conversation.

Putnam Insights Enterprise Narrative Sprint is a focused advisory engagement for companies that need greater clarity before a financing, clinical milestone, strategic partnership, website relaunch, commercialization effort, or other critical period of growth.

A focused advisory engagement for companies that need clarity before a financing, milestone, partnership, or relaunch. Through structured discovery and executive interviews, we define the narrative, align leadership language, and translate the story into investor-ready communications.

SECTORS

Focused on emerging life sciences.

01

Biotechnology

02

Biopharma

03

Medical devices

04

Diagnostics

05

Digital health

06

Healthcare and enabling technologies